Potomac Capital Management, Inc.

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 1418746 NEW YORK, NY

Position in FENC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,412,300

+$1,032,240 QoQ

Shares Held

224,400

0.0% QoQ

Ownership

0.640%

of shares outstanding

% of Portfolio

1.87%

of 13F equity value

Holder Rank

#11

of 104 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Potomac Capital Management, Inc. holds $4,921,092 across 3 Biotechnology names. FENC ranks #1 (49.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FENC	Fennec Pharmaceuticals Inc. This page	224,400	$2,412,300
2	GANX	Gain Therapeutics, Inc.	946,400	$1,921,192
3	CDXS	Codexis, Inc.	260,000	$587,600

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,412,300	224,400	0.0%	Shares	Sole	2026-08-14
2026-03-31	$1,380,060	224,400	+136.0%	Shares	Sole	2026-05-14
2025-12-31	$732,270	95,100	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.